Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Figure S1 Overall survival curves by PAM50 classification (for A-F) all patients from METABRIC cohort; (G-L) hormone therapy-treated patients. PAM50 classification was already determined in the METABRIC cohort and accessed through cBioportal. (PDF 1142 kb)